Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/07/2003WO2003064682A1 Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes
08/07/2003WO2003064680A2 Light activated gene transduction using ultraviolet light for cell targeted gene delivery
08/07/2003WO2003064667A1 Process for the reversible functional inactivation of the mismatch repair system
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064665A2 Viral vector
08/07/2003WO2003064664A1 Physiologically regulated erythropoietin- exprressing vector for the treatment of anaemia
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064661A1 Identification of characteristic specific genes of vegetal organisms
08/07/2003WO2003064660A1 Hybrid plasmid pzzsa coding the synthesis of angiogenin protein and escherichia coli bl21 (des) pzzsa strain as the superproducer of the recombinant chimeric protein of human angiogenin
08/07/2003WO2003064659A1 Methods and compositions for optimizing recombinant expression
08/07/2003WO2003064658A1 Alpha 1,3 galactosyltransferase mutant pigs
08/07/2003WO2003064657A1 A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
08/07/2003WO2003064656A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003WO2003064655A1 Sugar chain synthases
08/07/2003WO2003064654A1 Human serine/threonine protein kinase
08/07/2003WO2003064653A2 Method for overexpressing dehydrogenases
08/07/2003WO2003064652A1 Method for the production of zymosterol and/or the biosynthetic intermediate and/or subsequent products thereof in transgenic organisms
08/07/2003WO2003064651A2 Regulation of human membrane-type serine protease
08/07/2003WO2003064649A1 Promoter expressing foreign gene in root and shoot apex
08/07/2003WO2003064648A1 Method of making libraries of anti-ligands
08/07/2003WO2003064647A1 Method of controlling circadian rhythm
08/07/2003WO2003064645A1 Novel n-acetylgalactosamine transferase and nucleic acid encoding the same
08/07/2003WO2003064644A1 Method of line retro-position
08/07/2003WO2003064638A2 Elongase gene and method for producing polyunsaturated fatty acids
08/07/2003WO2003064633A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/07/2003WO2003064631A1 Methods of suppressing gene expression
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064627A2 Chimeric bird from embryonic stem cells
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064624A2 Molecular hepatotoxicology modeling
08/07/2003WO2003064623A2 Methods and vectors for facilitating site-specific recombination
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064621A2 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
08/07/2003WO2003064615A2 Amplifying repetitive nucleic acid sequences
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064611A2 Methods for creating recombination products between nucleotide sequences
08/07/2003WO2003064607A2 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064605A2 Crude biological derivatives competent for nucleic acid detection
08/07/2003WO2003064604A2 Translation profiling
08/07/2003WO2003064602A2 Methods of modulating cold sensory perception
08/07/2003WO2003064600A2 The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
08/07/2003WO2003064597A2 Aggrecanase molecules
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064595A2 Recombinant herpesvirus of turkeys and use thereof
08/07/2003WO2003064589A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064469A2 Regulation of human hematopoietin receptor-like protein
08/07/2003WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003WO2003064465A2 Prkag3 gene promoter and uses thereof
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003064459A1 Peptides for increasing transfection efficiency
08/07/2003WO2003064453A2 Trojan inhibitors, method for the production and use thereof
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064446A2 Plasma protein-binding peptides from bacterial curli
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063827A1 Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol)
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063785A2 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
08/07/2003WO2003063784A2 MOLECULES THAT MODULATE GαQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063765A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system
08/07/2003WO2003063725A2 Methods of preventing and treating flavivirus infection in animals
08/07/2003WO2003063688A2 Protein modification and maintenance molecules
08/07/2003WO2003063679A2 Hepatitis e virus clones and methods of their use
08/07/2003WO2003063586A1 Transgenic animals expressing prkag3
08/07/2003WO2003063581A2 Compositions and methods for increasing animal size and growth rate
08/07/2003WO2003054199A3 Phytases and method for producing these phytases
08/07/2003WO2003048375B1 Hybrid glycosylated products and their production and use
08/07/2003WO2003046132A3 Antisense modulation of myd88 expression
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003035834A3 Compositions and methods for making mutations in cell lines and animals
08/07/2003WO2003030826A3 Antisense modulation of insulin-like growth factor binding protein 5 expression
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003020916A8 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
08/07/2003WO2003018797A3 Method and device for integrated protein expression, purification and detection
08/07/2003WO2003018788B1 Improved nitroreductase enzymes
08/07/2003WO2003018742A3 Recombinant l-asparaginase erwinia caratovora
08/07/2003WO2003016516A3 Kinase crystal structures and materials and methods for kinase activation
08/07/2003WO2003008640A3 Asthma-associated gene
08/07/2003WO2003008534A8 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
08/07/2003WO2003006618A3 Nucleic acid-associated proteins
08/07/2003WO2003004634A3 Carboxypeptidase of cocoa
08/07/2003WO2003002741A8 Nucleic acids encoding nuclear receptors
08/07/2003WO2003000919B1 Method for detecting diseases caused by chromosomal imbalances
08/07/2003WO2002099105A3 Methods for modifying the cpg content of polynucleotides
08/07/2003WO2002096948A3 Engineered tetravalent antibodies and methods of use
08/07/2003WO2002092825B1 Retroviral vectors for gene therapy
08/07/2003WO2002090539A3 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
1 ... 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 ... 4023